K Number
K972248
Device Name
NELLCOR PURITAN BENNETT GEMINI
Date Cleared
1997-09-12

(88 days)

Product Code
Regulation Number
868.5895
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdparty
Intended Use
The Gemini is intended to provide continuous pressure support ventilation to patients requiring respiratory support within a sub-acute care environment. It is intended to be used on adults and children weighing at least 44 lbs (20 kq) for all modes except invasive VTV, which requires a minimum weight of 88 pounds (40 kg). The Gemini should not be used by patients requiring device performance outside the published device specifications. For example, some patients (such as those having low compliance or high resistance) will be treated more appropriately with ventilators having the ability to deliver higher pressures. Gemini is intended to be used in a variety of hospital environments including general hospital floors, emergency rooms, recovery rooms, ICUs and sub-acute environments. It may also be used in hospital-like settings such as sub-acute care centers and nursing homes. It is not intended to be used in home environments or for transport. Gemini is not intended for delivery of anesthetic gases. Volumes less than 200 ml are contraindicated when using volume ventilation.
Device Description
The Gemini has been designed to target physicians treating patients with moderate respiratory insufficiencies. The Gemini provides ventilation modes, alarms and safety features (active exhalation valve) that make it a safer and more effective selection than products carrying an MNS or MNT product code at a fraction of the cost for typical ICU ventilators. Both invasive and non-invasive ventilation are indicated. The Gemini ventilator uses a blower based breath delivery system. The ventilator provides four ventilation modes. These are: 1. Pressure Support Ventilation (PSV) 2. Pressure Support Ventilation with Minimum Respiratory Rate (PSV-MR) 3. Pressure Control Ventilation (PCV) 4. Volume Targeted Ventilation (VTV) A Volume Priority option can be enabled in both the PSV-MR and PCV modes. Gemini also has a proximal exhalation valve in the patient circuit that inhibits rebreathing of air. The operator communicates with the ventilator through a user interface incorporating three membrane keys, four rotary knobs and an LCD message display window. The LCD display enhances or augments visual/audible display of alarms, settings, modes, menus, and specialized calibration and testing procedures. Safety is enhanced through a software-based settings locking mechanism and the requirement that all changes require a minimum of two actions. Gemini uses standard domestic (US) 110-115 Vac and European 220-230 Vac power. No battery is available for the device at the time of this submission. Accessories included with the ventilator are: 1. Gemini ventilator 2. soft carrying case 3. 6-foot 22 mm hose 4. 6-foot exhalation control tubing 5. 6-foot pressure monitoring tube 6. exhalation valve 7. Operator Manual 8. patient mask and harness (optional) 9. model CM 5000 low/high inspiration pressure alarm (optional) 10. model 7820 oxygen monitor (optional)
More Information

Not Found

No
The document describes a standard ventilator with various modes and safety features, but there is no mention of AI or ML in the device description, intended use, or performance studies. The "Mentions AI, DNN, or ML" field is explicitly marked as "Not Found".

Yes.
The device is a ventilator intended to provide continuous pressure support ventilation to patients requiring respiratory support, which indicates a therapeutic purpose.

No

Explanation: The device, Gemini, is a ventilator intended to provide continuous pressure support ventilation, not to diagnose medical conditions.

No

The device description clearly outlines hardware components such as a blower-based breath delivery system, membrane keys, rotary knobs, an LCD display, and various accessories like hoses and valves. While it mentions software for control and safety features, it is integrated into a physical device.

Based on the provided text, the Gemini device is not an IVD (In Vitro Diagnostic).

Here's why:

  • Intended Use: The intended use clearly states that the Gemini is for providing continuous pressure support ventilation to patients requiring respiratory support. This is a therapeutic intervention, not a diagnostic test performed on samples taken from the body.
  • Device Description: The description details a ventilator with various ventilation modes, alarms, and safety features. These are all related to providing respiratory support directly to the patient.
  • Lack of IVD Characteristics: There is no mention of the device being used to examine specimens (blood, urine, tissue, etc.) or to provide information about a patient's health status based on such examination.

Therefore, the Gemini is a therapeutic medical device used for respiratory support, not an in vitro diagnostic device.

N/A

Intended Use / Indications for Use

The Gemini is intended to provide continuous pressure support ventilation to patients requiring respiratory support within a sub-acute care environment. It is intended to be used on adults and children weighing at least 44 lbs (20 kq) for all modes except invasive VTV, which requires a minimum weight of 88 pounds (40 kg). The Gemini should not be used by patients requiring device performance outside the published device specifications. For example, some patients (such as those having low compliance or high resistance) will be treated more appropriately with ventilators having the ability to deliver higher pressures.
Gemini is intended to be used in a variety of hospital environments including general hospital floors, emergency rooms, recovery rooms, ICUs and sub-acute environments. It may also be used in hospital-like settings such as sub-acute care centers and nursing homes. It is not intended to be used in home environments or for transport.
Gemini is not intended for delivery of anesthetic gases. Volumes less than 200 ml are contraindicated when using volume ventilation.

The Gemini Ventilator is intended to provide invasive or non-invasive pressure support ventilation to pediatric and adult patients requiring respiratory support. For invasive and non-invasive pressure ventilation, and non-invasive volume targeted ventilation, the patient should weigh no less than 44 pounds (20 kg). For invasive volume targeted ventilation, the patient should be at least 88 pounds (40 kg). Pediatric restrictions include those patients who require invasive ventilation using an ET4 or smaller diameter tube. The Gemini can be used in hospital and hospital-like settings such as the ICU, sub-acute care and nursing home settings. This device is intended to be used on the order, and under the supervision, of a physician.

Product codes (comma separated list FDA assigned to the subject device)

73CBK

Device Description

The Gemini has been designed to target physicians treating patients with moderate respiratory insufficiencies. The Gemini provides ventilation modes, alarms and safety features (active exhalation valve) that make it a safer and more effective selection than products carrying an MNS or MNT product code at a fraction of the cost for typical ICU ventilators. Both invasive and non-invasive ventilation are indicated.

The Gemini ventilator uses a blower based breath delivery system. The ventilator provides four ventilation modes. These are:

    1. Pressure Support Ventilation (PSV)
    1. Pressure Support Ventilation with Minimum Respiratory Rate (PSV-MR)
    1. Pressure Control Ventilation (PCV)
    1. Volume Targeted Ventilation (VTV)

A Volume Priority option can be enabled in both the PSV-MR and PCV modes. Gemini also has a proximal exhalation valve in the patient circuit that inhibits rebreathing of air.

The operator communicates with the ventilator through a user interface incorporating three membrane keys, four rotary knobs and an LCD message display window. The LCD display enhances or augments visual/audible display of alarms, settings, modes, menus, and specialized calibration and testing procedures. Safety is enhanced through a software-based settings locking mechanism and the requirement that all changes require a minimum of two actions.

Gemini uses standard domestic (US) 110-115 Vac and European 220-230 Vac power. No battery is available for the device at the time of this submission. Accessories included with the ventilator are:

  • Gemini ventilator 1.
    1. soft carrying case
    1. 6-foot 22 mm hose
    1. 6-foot exhalation control tubing
    1. 6-foot pressure monitoring tube
    1. exhalation valve
  • Operator Manual 7.
    1. patient mask and harness (optional)
  • model CM 5000 low/high inspiration pressure alarm (optional) ு.
    1. model 7820 oxygen monitor (optional)

Mentions image processing

Not Found

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

Not Found

Anatomical Site

Not Found

Indicated Patient Age Range

pediatric and adult patients

Intended User / Care Setting

The Gemini is intended to be used on the order, and under the supervision, of a physician.
sub-acute care environment.
a variety of hospital environments including general hospital floors, emergency rooms, recovery rooms, ICUs and sub-acute environments. It may also be used in hospital-like settings such as sub-acute care centers and nursing homes. It is not intended to be used in home environments or for transport.

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Not Found

Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)

Comprehensive system level functional testing was performed to confirm that the Gemini Ventilator meets all stated performance specifications. Performance tests for each of the ventilator critical subsystems were also conducted. It passed all tests.

Electrical, mechanical, environmental and EMC testing was performed to confirm that the Gemini Ventilator complies with the November 1993 draft Reviewer Guidance for Premarket Notification Submissions published by the Anesthesiology and Respiratory Devices Branch of the Division of Cardiovascular, Respiratory and Neurological Devices. It passed all tests.

All software was tested in compliance with the Reviewer Guidance for Computer Controlled Medical Devices Undergoing 510(k) Review published by the Office of Device Evaluation within the Center for Devices and Radiological Health.

Reliability testing is being performed to estimate the Mean Time Between Failure (MTBF) and Life Testing of the product.

Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)

Not Found

Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.

K950484

Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.

Not Found

Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).

Not Found

§ 868.5895 Continuous ventilator.

(a)
Identification. A continuous ventilator (respirator) is a device intended to mechanically control or assist patient breathing by delivering a predetermined percentage of oxygen in the breathing gas. Adult, pediatric, and neonatal ventilators are included in this generic type of device.(b)
Classification. Class II (performance standards).

0

Image /page/0/Picture/0 description: The image shows a date that is written in all caps. The date reads SEP 1 2 1997. The month is abbreviated to three letters. The numbers are written in a simple font.

K72248

19. SUMMARY OF SAFETY AND EFFECTIVENESS

A summary of the safety and effectiveness has been prepared for Nellcor Puritan Bennett Gemini Ventilator system in compliance with the Safe Medical Device Act of 1990. The summary of safety and effectiveness is presented on the following pages within this section.

19.1 Manufacturer Name

Nellcor Puritan Bennett Ireland Ltd. Mervue, Galway, Ireland Phone: 011-353-91-753771

19.2 Sponsor Name

Nellcor Puritan Bennett Inc. 10200 Valley View Rd. Eden Prairie, MN 55344 Phone: (612)947-5549

19.3 Proprietary Name of Device

Nellcor Puritan Bennett Inc. Gemini Ventilator

19.4 Common Name of Device

Continuous ventilator

19.5 Device Classification

Devices of this generic type have been classified as Class II by the Respiratory Devices Panel. Devices of this type have a classification code of 73CBK regulated under 21 CFR 868.5895.

19.6 Intended Use

The Gemini is intended to provide continuous pressure support ventilation to patients requiring respiratory support within a sub-acute care environment. It is intended to be used on adults and children weighing at least 44 lbs (20 kq) for all modes except invasive VTV, which requires a minimum weight of 88 pounds (40 kg). The Gemini should not be used by patients requiring device performance outside the published device specifications. For example, some patients (such as those having low compliance or high resistance) will be treated more appropriately with ventilators having the ability to deliver higher pressures.

1

Gemini is intended to be used in a variety of hospital environments including general hospital floors, emergency rooms, recovery rooms, ICUs and sub-acute environments. It may also be used in hospital-like settings such as sub-acute care centers and nursing homes. It is not intended to be used in home environments or for transport.

Gemini is not intended for delivery of anesthetic gases. Volumes less than 200 ml are contraindicated when using volume ventilation.

19.7 Device Description

The Gemini has been designed to target physicians treating patients with moderate respiratory insufficiencies. The Gemini provides ventilation modes, alarms and safety features (active exhalation valve) that make it a safer and more effective selection than products carrying an MNS or MNT product code at a fraction of the cost for typical ICU ventilators. Both invasive and non-invasive ventilation are indicated.

The Gemini ventilator uses a blower based breath delivery system. The ventilator provides four ventilation modes. These are:

    1. Pressure Support Ventilation (PSV)
    1. Pressure Support Ventilation with Minimum Respiratory Rate (PSV-MR)
    1. Pressure Control Ventilation (PCV)
    1. Volume Targeted Ventilation (VTV)

A Volume Priority option can be enabled in both the PSV-MR and PCV modes. Gemini also has a proximal exhalation valve in the patient circuit that inhibits rebreathing of air.

The operator communicates with the ventilator through a user interface incorporating three membrane keys, four rotary knobs and an LCD message display window. The LCD display enhances or augments visual/audible display of alarms, settings, modes, menus, and specialized calibration and testing procedures. Safety is enhanced through a software-based settings locking mechanism and the requirement that all changes require a minimum of two actions.

Gemini uses standard domestic (US) 110-115 Vac and European 220-230 Vac power. No battery is available for the device at the time of this submission. Accessories included with the ventilator are:

  • Gemini ventilator 1.
    1. soft carrying case
    1. 6-foot 22 mm hose
    1. 6-foot exhalation control tubing
    1. 6-foot pressure monitoring tube
    1. exhalation valve
  • Operator Manual 7.

2

    1. patient mask and harness (optional)
  • model CM 5000 low/high inspiration pressure alarm (optional) ு.
    1. model 7820 oxygen monitor (optional)

19.8 Predicate Device Equivalence

The model TBird VS Ventilation System (K950484) from Bird Products Corp. is the predicate device for the Nellcor Puritan Bennett Gemini Ventilator. Gemini offers a subset of the TBird's features, modes and indications. Whereas the TBird is indicated for all care conditions requiring mechanical ventilation, the Gemini indications are limited to sub-acute care. Both products are intended for institutional environments, but only the TBird claims non-emergency transport use as well. No transport is indicated for the Gemini. A more limited patient poulation is indicated for the Gemini as minimum patient weight is specified as 44 pounds (88 pounds for invasive VTV), instead of 22 pounds for the TBird. Also, an ET5 or larger tube is indicated for invasive pediatric use on the Gemini. Substantial equivalence to the TBird has been demonstrated through comprehensive specification comparison, and bench and laboratory testing.

19.9 Safety/Hazard Analysis

The Gemini hardware, software and functional performance were assessed for safety hazards to both caregiver and patient during normal condition (no fault) and single fault conditions. Label and warning precautions, as well as design techniques, were used to reduce the probability of occurrence or minimize the impact on the patient, or both. The intended use of the device, combined with the hazard/risk analysis results, indicates that the ventilator poses a moderate level of concern.

19.10 Performance Testing

Comprehensive system level functional testing was performed to confirm that the Gemini Ventilator meets all stated performance specifications. Performance tests for each of the ventilator critical subsystems were also conducted. It passed all tests.

Electrical, mechanical, environmental and EMC testing was performed to confirm that the Gemini Ventilator complies with the November 1993 draft Reviewer Guidance for Premarket Notification Submissions published by the Anesthesiology and Respiratory Devices Branch of the Division of Cardiovascular, Respiratory and Neurological Devices. It passed all tests.

All software was tested in compliance with the Reviewer Guidance for Computer Controlled Medical Devices Undergoing 510(k) Review published by the Office of Device Evaluation within the Center for Devices and Radiological Health.

Reliability testing is being performed to estimate the Mean Time Between Failure (MTBF) and Life Testing of the product.

3

No clinical studies were performed on the Gemini Ventilator as safety and effectiveness are confirmed through comprehensive bench testing.

19.11 Conclusion

NPB has concluded that the Gemini Ventilator meets its stated performance specifications and the criteria outlined in the FDA's Reviewer Guidance for Premarket Notification Submissions dated November 1993 and the Reviewer Guidance for Computer Contolled Medical Devices Undergoing 510(k) Review. We conclude that the device will operate safely in its intended environments and will be effective in fulfilling its intended use. Given the intended use and patient criticality level, the Gemini features are as safe and effective as the respective features provided on the TBird predicate device.

4

Image /page/4/Picture/1 description: The image is a black and white logo for the U.S. Department of Health & Human Services. The logo features the department's symbol, which is a stylized caduceus, a symbol often associated with medicine and healthcare. The words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" are arranged in a circular fashion around the symbol.

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20856

SEP 1 2 1997

Mr. Chris Hadland Nellcor Puritan Bennett, Inc. 10200 Valley View Road Eden Prairie, Minnesota 55344

Re: K972248 Nellcor Puritan Bennett Gemini Ventilator Regulatory Class: II (two) Product Code: 73 СВК Dated: June 13, 1997 Received: June 16, 1997

Dear Mr. Hadland:

We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The qeneral controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Requlations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the current Good Manufacturing Practice requirements, as set forth in the Quality System Regulation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic (QS) inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations.

5

Page 2 - Mr. Chris Hadland

This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4648. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97).

Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its internet address "http://www.fda.gov/cdrh/dsmamain.html".

Sincerely yours,

Thomas J. Callahan

Thomas J. Callahan, Ph.D. Director Division of Cardiovascular, Respiratory, and Neuroloqical Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

6

STATEMENT OF INTENDED USE

Product Description:

The Gemini Ventilator provides continuous pressure support-based ventilation to patients requiring respiratory support. It is capable of providing both patient and machine-triggered breaths utilizing numerous breathing modes. Patient breathing patterns are monitored with both pressure and flow sensors. Breaths are delivered with a blower, driven by an electrically powered motor. Visual and audible alarms sound for various equipment, patient interface and physiologic fault conditions.

Intended Use and Indications:

The Gemini Ventilator is intended to provide invasive or non-invasive pressure support ventilation to pediatric and adult patients requiring respiratory support. For invasive and non-invasive pressure ventilation, and non-invasive volume targeted ventilation, the patient should weigh no less than 44 pounds (20 kg). For invasive volume targeted ventilation, the patient should be at least 88 pounds (40 kg). Pediatric restrictions include those patients who require invasive ventilation using an ET4 or smaller diameter tube. The Gemini can be used in hospital and hospital-like settings such as the ICU, sub-acute care and nursing home settings. This device is intended to be used on the order, and under the supervision, of a physician.

Concurence of CDRH, Office of Device Evaluation

510(k) number: _______________________________________________________________________________________________________________________________________________________________

  • Prescription Use